Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPH Gross Margin

The Gross Margin of Recro Pharma Inc (REPH) is 2630.44%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

REPH Gross Margin - Historical Value
Date Value
2021-12-31 2630.44%
2020-12-31 18.60%
2019-12-31 48.62%
2018-12-31 44.20%
2017-12-31 46.83%
2016-12-31 46.42%
2015-12-31 46.01%
REPH Gross Margin - Peers Comparison